Rejuvel Bio-Sciences, Inc.
NUUU
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | 50.40K | 36.10K | 70.40K | 30.40K | 18.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.40K | 36.10K | 70.40K | 30.40K | 18.40K |
| Cost of Revenue | 10.20K | 4.90K | 9.20K | 74.20K | 200.00 |
| Gross Profit | 40.20K | 31.30K | 61.20K | -43.80K | 18.20K |
| SG&A Expenses | 275.80K | 605.00K | 272.10K | 196.10K | 210.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 286.00K | 609.80K | 281.30K | 270.30K | 210.90K |
| Operating Income | -235.60K | -573.70K | -211.00K | -239.90K | -192.60K |
| Income Before Tax | -327.50K | -628.00K | -244.80K | 148.30K | 175.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -327.50K | -628.00K | -244.80K | 148.30K | 175.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -327.50K | -628.00K | -244.80K | 148.30K | 175.20K |
| EBIT | -235.60K | -573.70K | -211.00K | -239.90K | -192.60K |
| EBITDA | -233.50K | -571.60K | -208.90K | -237.30K | -191.10K |
| EPS Basic | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 50.82M | 50.74M | 50.26M | 48.03M | 106.19M |
| Average Diluted Shares Outstanding | 50.82M | 50.74M | 50.26M | 48.03M | 106.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
